Status:
COMPLETED
Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD
Lead Sponsor:
Convexity Scientific Inc
Collaborating Sponsors:
COPD Foundation
Conditions:
COPD
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The clinical objectives of this study are to determine whether utilization of the Wellinks COPD Solution can improve quality of life for patients with COPD, can reduce healthcare resource utilization ...
Eligibility Criteria
Inclusion
- COPD diagnosis (confirmed by the patient and assumed based on participation in COPD PPRN)
- Home telephone (landline or mobile) and internet access
- Smartphone: iPhone 6S or later model, running iOS 14.0 or later; Android 6 or later model
- Proficient in English language
- Living/staying in the United States throughout the study duration
- Willing and able to comply with study requirements
- Able to provide written informed consent
Exclusion
- Current participation in other interventional clinical trials
- Current participation in a pulmonary rehabilitation program
Key Trial Info
Start Date :
January 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 8 2022
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT05259280
Start Date
January 5 2022
End Date
September 8 2022
Last Update
November 2 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Wellinks
New Haven, Connecticut, United States, 06511
2
COPD Foundation
Washington D.C., District of Columbia, United States, 20002